Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2026-03-05 @ 8:51 AM
Study NCT ID:
NCT04405167
Status:
TERMINATED
Last Update Posted:
2025-10-07
First Post:
2020-03-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
Sponsor:
University of Pennsylvania
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |
Keywords: